Austco Healthcare Limited announces a 39% increase in revenue from customers over the prior comparative period (pcp) to $58.2 million for FY24.
The revenue growth of $16.2 million was driven by a combination of organic growth from existing operations of $7.0 million or 17% growth, together with revenues from the two acquisitions made through the year, being Teknocorp (purchased 27 November 2023) with $6.5 million revenue and Amentco (purchased 1 May 2024) with $2.7 million revenue.
The combination of double digit organic revenue growth and the successful integration of the two acquired businesses into the group provides for record FY24 results and sets a platform for future growth and success.
Please find the complete document here.
